PHREESIA INC (PHR) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PHR - US71944F1066 - Common Stock
16.51 USD
-0.04 (-0.24%)
Overall PHR gets a fundamental rating of 4 out of 10. We evaluated PHR against 35 industry peers in the Health Care Technology industry. The financial health of PHR is average, but there are quite some concerns on its profitability. PHR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
PHR had negative earnings in the past year.
PHR had a positive operating cash flow in the past year.
In the past 5 years PHR always reported negative net income.
In multiple years PHR reported negative operating cash flow during the last 5 years.
1.2 Ratios
PHR's Return On Assets of -1.27% is fine compared to the rest of the industry. PHR outperforms 71.43% of its industry peers.
PHR's Return On Equity of -1.68% is fine compared to the rest of the industry. PHR outperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.27% | ||
| ROE | -1.68% | ||
| ROIC | N/A |
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 68.20%, PHR is in the better half of the industry, outperforming 68.57% of the companies in the same industry.
In the last couple of years the Gross Margin of PHR has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for PHR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
2. Health
2.1 Basic Checks
PHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHR has more shares outstanding
Compared to 5 years ago, PHR has more shares outstanding
The debt/assets ratio for PHR is higher compared to a year ago.
2.2 Solvency
PHR has an Altman-Z score of 4.55. This indicates that PHR is financially healthy and has little risk of bankruptcy at the moment.
PHR has a better Altman-Z score (4.55) than 80.00% of its industry peers.
PHR has a debt to FCF ratio of 0.27. This is a very positive value and a sign of high solvency as it would only need 0.27 years to pay back of all of its debts.
PHR's Debt to FCF ratio of 0.27 is fine compared to the rest of the industry. PHR outperforms 80.00% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that PHR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, PHR is in line with its industry, outperforming 57.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.27 | ||
| Altman-Z | 4.55 |
ROIC/WACCN/A
WACC9.8%
2.3 Liquidity
PHR has a Current Ratio of 2.44. This indicates that PHR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PHR (2.44) is comparable to the rest of the industry.
A Quick Ratio of 2.44 indicates that PHR has no problem at all paying its short term obligations.
The Quick ratio of PHR (2.44) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 93.75% over the past year.
Looking at the last year, PHR shows a quite strong growth in Revenue. The Revenue has grown by 14.33% in the last year.
Measured over the past years, PHR shows a very strong growth in Revenue. The Revenue has been growing by 27.46% on average per year.
EPS 1Y (TTM)93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)14.33%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%12.67%
3.2 Future
The Earnings Per Share is expected to grow by 38.62% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.66% on average over the next years. This is quite good.
EPS Next Y96.92%
EPS Next 2Y50.96%
EPS Next 3Y38.62%
EPS Next 5YN/A
Revenue Next Year13.98%
Revenue Next 2Y13.02%
Revenue Next 3Y12.39%
Revenue Next 5Y11.66%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 58.01, the valuation of PHR can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as PHR.
The average S&P500 Price/Forward Earnings ratio is at 23.84. PHR is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 58.01 |
4.2 Price Multiples
PHR's Enterprise Value to EBITDA ratio is in line with the industry average.
PHR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PHR is cheaper than 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.19 | ||
| EV/EBITDA | 44.91 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHR's earnings are expected to grow with 38.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.96%
EPS Next 3Y38.62%
5. Dividend
5.1 Amount
No dividends for PHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:PHR (12/22/2025, 10:44:59 AM)
16.51
-0.04 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners103.35%
Inst Owner Change3.13%
Ins Owners4.55%
Ins Owner Change6.1%
Market Cap989.11M
Revenue(TTM)463.20M
Net Income(TTM)-5.38M
Analysts84.76
Price Target34.48 (108.84%)
Short Float %6.08%
Short Ratio3.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8258.63%
Min EPS beat(2)115.6%
Max EPS beat(2)16401.7%
EPS beat(4)4
Avg EPS beat(4)4149.43%
Min EPS beat(4)38.81%
Max EPS beat(4)16401.7%
EPS beat(8)8
Avg EPS beat(8)2083.66%
EPS beat(12)12
Avg EPS beat(12)1396.19%
EPS beat(16)16
Avg EPS beat(16)1052.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.56%
Min Revenue beat(2)-0.76%
Max Revenue beat(2)-0.37%
Revenue beat(4)0
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)-0.18%
Revenue beat(8)1
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)0.17%
Revenue beat(16)8
Avg Revenue beat(16)0.55%
PT rev (1m)-0.38%
PT rev (3m)-1%
EPS NQ rev (1m)125.34%
EPS NQ rev (3m)291.26%
EPS NY rev (1m)7.82%
EPS NY rev (3m)78.72%
Revenue NQ rev (1m)1.71%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 58.01 | ||
| P/S | 2.14 | ||
| P/FCF | 28.19 | ||
| P/OCF | 16.11 | ||
| P/B | 3.09 | ||
| P/tB | 6 | ||
| EV/EBITDA | 44.91 |
EPS(TTM)-0.07
EYN/A
EPS(NY)0.28
Fwd EY1.72%
FCF(TTM)0.59
FCFY3.55%
OCF(TTM)1.02
OCFY6.21%
SpS7.73
BVpS5.35
TBVpS2.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.27% | ||
| ROE | -1.68% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.2% | ||
| FCFM | 7.58% |
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
F-Score7
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.27 | ||
| Debt/EBITDA | 0.17 | ||
| Cap/Depr | 92.06% | ||
| Cap/Sales | 5.68% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 308.26% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 4.55 |
F-Score7
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)91.68%
Cap/Depr(5y)107.3%
Cap/Sales(3y)7.37%
Cap/Sales(5y)9.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y96.92%
EPS Next 2Y50.96%
EPS Next 3Y38.62%
EPS Next 5YN/A
Revenue 1Y (TTM)14.33%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%12.67%
Revenue Next Year13.98%
Revenue Next 2Y13.02%
Revenue Next 3Y12.39%
Revenue Next 5Y11.66%
EBIT growth 1Y89.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year250.04%
EBIT Next 3Y63.19%
EBIT Next 5Y37.25%
FCF growth 1Y150.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y235.86%
OCF growth 3YN/A
OCF growth 5Y108.09%
PHREESIA INC / PHR FAQ
Can you provide the ChartMill fundamental rating for PHREESIA INC?
ChartMill assigns a fundamental rating of 4 / 10 to PHR.
What is the valuation status for PHR stock?
ChartMill assigns a valuation rating of 4 / 10 to PHREESIA INC (PHR). This can be considered as Fairly Valued.
Can you provide the profitability details for PHREESIA INC?
PHREESIA INC (PHR) has a profitability rating of 2 / 10.
Is the dividend of PHREESIA INC sustainable?
The dividend rating of PHREESIA INC (PHR) is 0 / 10 and the dividend payout ratio is 0%.